TAUNS Laboratories (197A) · InitiativeFirst statedLatest Earnings presentation (2026-08-13): "Advanced"
Commercialization and performance improvements for new antibodies, Accu-Lead and other products
First written in FY2024. 4 of 5 entries say "Advanced", first in 2026-05-14. Latest entry: 2026-08-13.
5entries
3years
4from disclosures
How it moved
Same theme, other companies
Commercialization and Performance Improvement of the New Antibody and アキュリード ProductsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first